NCT06355102
The Development of Tinnitus in Patients With SSNHL: Insights From fMRI and Metabolomics
StatusUnknown
PhaseNot specified
Primary completion (estimated)
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 2 versions: 2 with changes below.
- Minor Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Enrolling by Invitation
- Notable Trial status: Not Yet Recruiting to Enrolling by Invitation
- Study sites: 0 to 1
- Interventions: Conventional treatment and care (Other)
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Brain function states
Timeframe: Acute phase (within 5 days after onset), 1 month, 3 months, and 6 months after onset
Serum metabolomics
Timeframe: Acute phase (within 5 days after onset)
Arms and interventions
SSNHL with Tinnitus
Patients diagnosed with sudden sensorineural hearing loss accompanied with acute occuring tinnitus symptoms.
SSNHL without Tinnitus
Patients diagnosed with sudden sensorineural hearing loss without acute occuring tinnitus symptoms.
Health Control
Healthy subjects with normal hearing and no tinnitus.
Other: Conventional treatment and care
Sites
1 site in 1 country
- Department of Otolaryngology, the First Affiliated Hospital, Nanjing Medical UniversityNanjing, Jiangsu, China